JNK1 activation mediates C5b-9-induced P0 mRNA instability and P0 gene expression in Schwann cells

Journal of the Peripheral Nervous System

Volumn 11, Issue 1, 2006, Pages 77-87

  David, Stefan ^a   Hila, Sorana ^a   Fosbrink, Matthew ^a   Rus, Horea ^a,b   Koski, Carol Lee ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

c Jun N terminal kinase; C5b 9; Complement activation; Protein zero; Schwann cells

Indexed keywords

COMPLEMENT COMPONENT C7; COMPLEMENT MEMBRANE ATTACK COMPLEX; DACTINOMYCIN; FIREFLY LUCIFERASE; GLYCOPROTEIN; MESSENGER RNA; PROTEIN P 0; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; RAT; RNA STABILITY; SCHWANN CELL; TRANSCRIPTION REGULATION;

ANIMALS; BLOTTING, NORTHERN; COMPLEMENT MEMBRANE ATTACK COMPLEX; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION; MITOGEN-ACTIVATED PROTEIN KINASE 8; MYELIN P0 PROTEIN; RATS; RATS, SPRAGUE-DAWLEY; RNA STABILITY; RNA, MESSENGER; SCHWANN CELLS; TRANSCRIPTION, GENETIC;

EID: 33644766237     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1085-9489.2006.00067.x     Document Type: Article

References (63)

1. Aguayo AJ Charron L Bray GM 1976 Potential of Schwann cells from unmyelinated nerves to produce myelin: a quantitative ultrastructural and autoradiographic study J Neurocytol 5 565 573
2. Barr RK Bogoyevitch MA 2001 The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs) Int J Biochem Cell Biol 33 1047 1063
3. Bharucha VA Peden KW Tennekoon GI 1994 SV40 large T antigen with c-Jun down-regulates myelin P0 gene expression: a mechanism for papovaviral T antigen-mediated demyelination Neuron 12 627 637
4. Bottenstein JE Sato GH 1979 Growth of a rat neuroblastoma cell line in serum-free supplemented medium Proc Nat Acad Sci USA 76 514 517
5. Brockes JP Fields KL Raff MC 1979 Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve Brain Res 165 105 118
6. Brockes JP Raff MC 1979 Studies on cultured rat Schwann cells. II. Comparison with a rat Schwann cell line In Vitro 15 772 778
7. Carney DF Lang TJ Shin ML 1990 Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination J Immunol 145 623 629
8. Chen CY Gherzi R Andersen JS Gaietta G Jurchott K Royer HD Mann M Karin M 2000 Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation Genes Dev 14 1236 1248
9. Colello RJ Pott U 1997 Signals that initiate myelination in the developing mammalian nervous system Mol Neurobiol 15 83 100
10. Collins LR Minden A Karin M Brown JH 1996 Galpha12 stimulates c-Jun NH2-terminal kinase through the small G proteins Ras and Rac J Biol Chem 271 17349 17353
11. Compston DA Morgan BP Campbell AK Wilkins P Cole G Thomas ND Jasani B 1989 Immunocytochemical localization of the terminal complement complex in multiple sclerosis Neuropathol Appl Neurobiol 15 307 316
12. Dashiell SM Koski CL 1999 Sublytic terminal complement complexes decrease P0 gene expression in Schwann cells J Neurochem 73 2321 2330
13. Dashiell SM Rus H Koski CL 2000 Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis Glia 30 187 198
14. Dashiell SM Vanguri P Koski CL 1997 Dibutyryl cyclic AMP and inflammatory cytokines mediate C3 expression in Schwann cells Glia 20 308 321
15. Eichberg J 2002 Myelin P0: new knowledge and new roles Neurochem Res 27 1331 1340
16. Feasby TE Gilbert JJ Hahn AF Neilson M 1987 Complement depletion suppresses Lewis rat experimental allergic neuritis Brain Res 419 97 103
17. Giese KP Martini R Lemke G Soriano P Schachner M 1992 Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons Cell 71 565 576
18. Hafer-Macko CE Sheikh KA Li CY Ho TW Cornblath DR McKhann GM Asbury AK Griffin JW 1996 Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy Ann Neurol 39 625 635
19. Hila S Soane L Koski CL 2001 Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phosphorylation of BAD Glia 36 58 67
20. Ip YT Davis RJ 1998 Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development Curr Opin Cell Biol 10 205 219
21. Jaegle M Mandemakers W Broos L Zwart R Karis A Visser P Grosveld F Meijer D 1996 The POU factor Oct-6 and Schwann cell differentiation Science 273 507 510
22. Jaegle M Meijer D 1998 Role of Oct-6 in Schwann cell differentiation Microsc Res Tech 41 372 378
23. Jessen KR Mirsky R 2002 Signals that determine Schwann cell identity J Anat 200 367 376
24. Jessen KR Mirsky R Morgan L 1987 Axonal signals regulate the differentiation of non-myelin-forming Schwann cells: an immunohistochemical study of galactocerebroside in transected and regenerating nerves J Neurosci 7 3362 3369
25. Koski CL 1987 Complement-fixing antiperipheral myelin antibodies and C9 neoantigen in serum of patients with Guillain-Barre syndrome: quantitation, kinetics, and clinical correlation Ann N Y Acad Sci 505 319 325
26. Koski CL 1992 Humoral mechanisms in immune neuropathies Neurol Clin 10 629 649
27. Koski CL 1997 Mechanisms of Schwann cell damage in inflammatory neuropathy J Infect Dis 176 S169 S172
28. Koski CL Khurana R Mayer RF 1986 Guillain-Barre syndrome Am Fam Physician 34 198 210
29. Koski CL Sanders ME Swoveland PT Lawley TJ Shin ML Frank MM Joiner KA 1987 Activation of terminal components of complement in patients with Guillain-Barre syndrome and other demyelinating neuropathies J Clin Invest 80 1492 1497
30. Lang TJ Badea TC Wade R Shin ML 1997 Sublytic terminal complement attack on myotubes decreases the expression of mRNAs encoding muscle-specific proteins J Neurochem 68 1581 1589
31. Lemke G Chao M 1988 Axons regulate Schwann cell expression of the major myelin and NGF receptor genes Development 102 499 504
32. Lemke G Lamar E Patterson J 1988 Isolation and analysis of the gene encoding peripheral myelin protein zero Neuron 1 73 83
33. Mead RJ Singhrao SK Neal JW Lassmann H Morgan BP 2002 The membrane attack complex of complement causes severe demyelination associated with acute axonal injury J Immunol 168 458 465
34. Menichella DM Arroyo EJ Awatramani R Xu T Baron P Vallat JM Balsamo J Lilien J Scarlato G Kamholz J Scherer SS Shy ME 2001 Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells Mol Cell Neurosci 18 606 618
35. Ming XF Kaiser M Moroni C 1998 c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells EMBO J 17 6039 6048
36. Mirsky R Jessen KR 1999 The neurobiology of Schwann cells Brain Pathol 9 293 311
37. Morrison S Mitchell LS Ecob-Prince MS Griffiths IR Thomson CE Barrie JA Kirkham D 1991 P0 gene expression in cultured Schwann cells J Neurocytol 20 769 780
38. Nataf S Carroll SL Wetsel RA Szalai AJ Barnum SR 2000 Attenuation of experimental autoimmune demyelination in complement-deficient mice J Immunol 165 5867 5873
39. Niculescu F Niculescu T Rus H 2004 C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis Exp Mol Pathol 76 17 23
40. Niculescu F Rus H van Biesen T Shin ML 1997 Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent J Immunol 158 4405 4412
41. Parkinson DB Bhaskaran A Droggiti A Dickinson S D'Antonio M Mirsky R Jessen KR 2004 Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death J Cell Biol 164 385 394
42. Peng H Takano T Papillon J Bijian K Khadir A Cybulsky AV 2002 Complement activates the c-Jun N-terminal kinase/stress-activated protein kinase in glomerular epithelial cells J Immunol 169 2594 2601
43. Quarles RH 1997 Glycoproteins of myelin sheaths J Mol Neurosci 8 1 12
44. Rus H Niculescu F Badea T Shin ML 1997 Terminal complement complexes induce cell cycle entry in oligodendrocytes through mitogen activated protein kinase pathway Immunopharmacology 38 177 187
45. Rus HG Niculescu F Shin ML 1996 Sublytic complement attack induces cell cycle in oligodendrocytes J Immunol 156 4892 4900
46. Sawant-Mane S Clark MB Koski CL 1991 In vitro demyelination by serum antibody from patients with Guillain-Barre syndrome requires terminal complement complexes Ann Neurol 29 397 404
47. Sawant-Mane S Estep A III Koski CL 1994 Antibody of patients with Guillain-Barre syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotype J Neuroimmunol 49 145 152
48. Scherer SS 1997 The biology and pathobiology of Schwann cells Curr Opin Neurol 10 386 397
49. Shah G 1999 Why do we still use serum in the production of biopharmaceuticals? Dev Biol Stand 99 17 22
50. Shin ML Koski CL 1992 The complement system in demyelination. In: Myelin: Biology and Chemistry Martenson RE (Ed). CRC Press Boca Raton, FL, pp 801 831
51. Shirazi Y Rus HG Macklin WB Shin ML 1993 Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes J Immunol 150 4581 4590
52. Soane L Cho HJ Niculescu F Rus H Shin ML 2001 C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway J Immunol 167 2305 2311
53. Soane L Rus H Niculescu F Shin ML 1999 Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation J Immunol 163 6132 6138
54. Stewart HJ 1995 Expression of c-Jun, Jun B, Jun D and cAMP response element binding protein by Schwann cells and their precursors in vivo and in vitro Eur J Neurosci 7 1366 1375
55. Stoll G Schmidt B Jander S Toyka KV Hartung HP 1991 Presence of terminal complement complex (C5b-9) precedes myelin degradation in immune mediated demyelination of the rat peripheral nervous system Ann Neurol 30 147 155
56. Takano T Cybulsky AV Yang X Aoudjit L 2001 Complement C5b-9 induces cyclooxygenase-2 gene transcription in glomerular epithelial cells Am J Physiol Renal Physiol 281 F841 F850
57. Tatum AH 1993 Large scale recovery of biologically active IgM (95% pure) from human plasma obtained by therapeutic plasmapheresis J Immunol Methods 158 1 4
58. Vanguri P Shin ML 1988 Hydrolysis of myelin basic protein in human myelin by terminal complement complexes J Biol Chem 263 7228 7234
59. Weinberg HJ Spencer PS 1976 Studies on the control of myelinogenesis. II. Evidence for neuronal regulation of myelin production Brain Res 113 363 378
60. Weston CR Davis RJ 2002 The JNK signal transduction pathway Curr Opin Genet Dev 12 14 21
61. Weston CR Lambright DG Davis RJ 2002 Signal transduction. MAP kinase signaling specificity Science 296 2345 2347
62. Yamauchi J Chan JR Shooter EM 2003 Neurotrophin 3 activation of TrkC induces Schwann cell migration through the c-Jun N-terminal kinase pathway Proc Nat Acad Sci USA 100 14421 14426
63. Zorick TS Lemke G 1996 Schwann cell differentiation Curr Opin Cell Biol 8 870 876